| Authors: |
Mehta-Shah N; Washington University School of Medicine in St. Louis, Saint Louis, MO., Zinzani PL; IRCCS Azienda Ospedalierao-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Jacobsen ED; Dana-Farber Cancer Institute, Boston, MA., Zain J; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Mead M; Division of Hematology/Oncology, University of California, Los Angeles (UCLA), Los Angeles, CA.; Clinical Research Solutions, ProPharma Group, Raleigh, NC., Casulo C; University of Rochester Medical Center - James P. Wilmot Cancer Institute, Rochester, NY., Gritti G; Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Pinter-Brown L; University of California-Irvine, Irvine, CA., Izutsu K; National Cancer Center Hospital, Tokyo, Japan., Sidransky D; Johns Hopkins University, Baltimore, MD., Bentur OS; Secura Bio, Inc, Berkeley Heights, NJ., Pro B; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY., Fox CP; School of Medicine, University of Nottingham, Nottingham, United Kingdom., Brammer JE; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, NY. |
